ArticleCureus2025
Inhaled Isopropyl Alcohol for Refractory Cannabis Hyperemesis Syndrome: A Case With Pneumomediastinum and Pneumothorax.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis hyperemesis syndrome (CHS) is a well-recognized condition associated with chronic cannabis use, characterized by recurrent nausea, retching, vomiting, and relief with hot showers. Management is challenging, particularly as symptoms are refractory to conventional antiemetic therapy. We report the case of a 26-year-old man with a history of daily cannabis use who presented with severe retching and vomiting, complicated by pneumothorax and pneumomediastinum. His nausea and retching persisted despite multiple antiemetic therapies but responded rapidly to inhaled isopropyl alcohol (IPA) swabs. This case highlights the potential role of non-pharmacological aromatherapy as a safe and effective adjunct in managing refractory CHS while also underscoring the serious complications that can occur from severe persistent emesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.